Ligand validation:1XU4

ANP: PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER

ANP is a Ligand Of Interest in 1XU4 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1XU4_ANP_A_401	85%	10%	0.112	0.976	2.84	1.53	14	3	1	0	100%	1
2FPL_ANP_A_401	92%	10%	0.094	0.985	2.7	1.6	11	4	0	0	100%	1
1T4G_ANP_A_401	92%	11%	0.088	0.977	2.64	1.57	11	3	0	0	100%	1
2I1Q_ANP_A_401	89%	8%	0.092	0.971	2.68	1.95	10	7	2	0	100%	1
2FPM_ANP_A_401	87%	11%	0.1	0.973	2.67	1.52	11	3	1	0	100%	1
3NTU_ANP_A_401	85%	5%	0.119	0.986	2.55	2.71	11	8	1	0	100%	1
8PS7_ANP_A_704	100%	43%	0.023	0.994	1.15	1.05	4	2	0	0	100%	1
1JQH_ANP_A_301	100%	5%	0.028	0.993	2.29	3	10	7	0	0	100%	1
8YNQ_ANP_C_505	100%	43%	0.03	0.992	1.16	1.07	4	2	7	0	100%	1
9AVR_ANP_A_501	100%	36%	0.034	0.991	1.05	1.46	2	5	2	0	100%	1
4BRA_ANP_A_1394	100%	12%	0.037	0.993	2.3	1.8	10	6	3	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.